Pioglitazone HCL and Metformin HCL 500 mg/1

Pioglitazone HCL and Metformin HCL 500 mg/1 tablets combine two active ingredients for managing blood sugar levels. This oral medication is commonly used in diabetes care to improve insulin sensitivity and reduce glucose production in the liver.

Pioglitazone HCL and Metformin HCL 500 mg/1 tablets are typically used to manage type 2 diabetes. Pioglitazone works by making your body more sensitive to insulin, while Metformin helps lower glucose production in the liver. Together, they help control blood sugar levels in adults with diabetes. This combination is often prescribed when diet and exercise alone are not enough to manage blood sugar.

Common effects of Pioglitazone HCL and Metformin HCL 500 mg/1 tablets may include weight gain, headache, and mild nausea. Some users may experience dizziness or muscle pain. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Pioglitazone HCL and Metformin HCL 500 mg/1 tablets should be used with caution in individuals with liver or kidney problems. It is important to monitor blood sugar levels regularly while taking this medication. Avoid alcohol consumption, as it can increase the risk of lactic acidosis. Always follow the advice of a healthcare professional.

Pioglitazone HCL and Metformin HCL 500 mg/1 tablets may interact with certain medications, including insulin, other diabetes drugs, and some antibiotics. Alcohol can increase the risk of lactic acidosis, so it should be avoided. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.